Malignant pleural mesothelioma shows a promising response to treatment with the antibody drug pembrolizumab, which is used to treat other cancers.
Source: MedicalNewsToday.com
Mesothelioma shows promising response to existing immunotherapy drug
Published in Health News
More from Health NewsMore posts in Health News »
- Aborted Fetus Brings Wrongful Death Suit; Simone Gold’s ‘Boyfriend’ Found Guilty
- Dupilumab Gets First FDA-Approved Indication for Prurigo Nodularis
- Program to Strengthen Mother-Infant Bond May Improve Preemie Brain Development
- Keeping Plavix After Short DAPT: Bleeding Benefit Emerges a Few Years After PCI
- Coffee and Early Death; Queen’s Cause of Death Revealed; Hospital Halts Trans Care
